New treatment for mantle cell lymphoma (MCL) now available for patients in the UK

VELCADE® (bortezomib) has been approved today in the UK for the first-line treatment of Mantle Cell Lymphoma (MCL), an aggressive subtype of blood cancers, collectively known as...